Vivos Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
Vivos Therapeutics, Inc. (VVOS) reported Stock Issued During Period, Shares, New Issues of 300.00 thousand shares for the 1-month period ending 2020-10-31, per its 10-K filed 2022-03-31.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2022-03-31
- 2020-10-31: Stock Issued During Period, Shares, New Issues 1 month 300.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|
| 2020-10-31 | 300.00K shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |